Effect of Self-administered tDCS in Patients With MDD

Summary

In this randomized, single-blinded clinical trial, 58 patients with major depressive disorder were assigned to active and sham tDCS stimulation groups in a 1:1 ratio, and treatment responses were evaluated biweekly over six weeks.

Timeline

Start

2017-11-16

Primary completion

2019-05-02

Completion

2019-05-02

Drugs

Indications